Published in

Association for Research in Vision and Ophthalmology, Investigative Ophthalmology & Visual Science, 8(53), p. 4748

DOI: 10.1167/iovs.12-10061

Links

Tools

Export citation

Search in Google Scholar

A NovelGUCY2DMutation, V933A, Causes Central Areolar Choroidal Dystrophy

Journal article published in 2012 by Anne E. Hughes, Weihua Meng, Andrew J. Lotery, Declan T. Bradley ORCID
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Red circle
Postprint: archiving forbidden
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO

Abstract

PURPOSE. To identify the genetic cause of central areolar choroidal dystrophy (CACD) in a large Northern Irish family. METHODS. We previously reported linkage of the locus for CACD in this family to an interval of approximately 5 cM on chromosome 17p13 flanked by polymorphic markers D17S1810 and CHLC GATA7B03. We undertook sequence capture, massively parallel sequencing and computational alignment, base-calling and annotation to identify a causative mutation. Conventional sequencing was used to confirm the results. RESULTS. Deep sequencing identified a single-base substitution in guanylate cyclase 2D, membrane (retina-specific) gene (GUCY2D). The novel mutation segregated with the disease phenotype and resulted in substitution of valine by alanine at position 933, within the catalytic domain of the protein. It altered a motif that is strongly conserved in a large number of distantly related proteins across several species and was predicted to have a damaging effect on protein activity. CONCLUSIONS. Mutations in GUCY2D have previously been associated with dominant cone-rod dystrophies (CORD6) and recessive forms of Leber's congenital amaurosis. This is the first report of a GUCY2D mutation causing CACD and adds to our understanding of genotype-phenotype correlation in this heterogeneous group of choroidoretinal dystrophies. (Invest Ophthalmol Vis Sci. 2012; 53:4748-4753) DOI: 10.1167/iovs.12-10061